ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Jennifer Pietenpol Named to IOM Cancer Policy Board

July 18, 2014

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012

Young Investigators Hold Their Own

September 28, 1979

Afinitor Significantly Reduced Tumor Size In TSC-Related Renal Angiomyolipomas

January 25, 2013

Reagan’s Freeze Chills NCI Plan To Hire Outsiders

January 30, 1981

Senate Subcommittee Okays $1 billion For NCI In FY 1980, Agrees To Block Obey Reprogramming

June 15, 1979